These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3766578)

  • 1. Stability of 1% rifampin suspensions prepared in five syrups.
    Krukenberg CC; Mischler PG; Massad EN; Moore LA; Chandler AD
    Am J Hosp Pharm; 1986 Sep; 43(9):2225-8. PubMed ID: 3766578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of extemporaneously compounded spironolactone suspensions.
    Mathur LK; Wickman A
    Am J Hosp Pharm; 1989 Oct; 46(10):2040-2. PubMed ID: 2816959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of 5-aminosalicylic acid suspension.
    Montgomery HA; Smith FM; Scott BE; White SJ; Gerald KB
    Am J Hosp Pharm; 1986 Jan; 43(1):118-20. PubMed ID: 3953581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of preparation method and storage on rifampin concentration in suspensions.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1994 Feb; 28(2):182-5. PubMed ID: 8173129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of allopurinol and of five antineoplastics in suspension.
    Dressman JB; Poust RI
    Am J Hosp Pharm; 1983 Apr; 40(4):616-8. PubMed ID: 6846371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of rifampin in two suspensions at room temperature.
    Nahata MC; Morosco RS; Hipple TF
    J Clin Pharm Ther; 1994 Aug; 19(4):263-5. PubMed ID: 7989407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of aqueous suspensions of disulfiram.
    Das Gupta V
    Am J Hosp Pharm; 1981 Mar; 38(3):363-4. PubMed ID: 7223750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of procainamide hydrochloride syrups compounded from capsules.
    Alexander KS; Pudipeddi M; Parker GA
    Am J Hosp Pharm; 1993 Apr; 50(4):693-8. PubMed ID: 8470687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of rifampin in SyrSpend SF.
    Sorenson B; Whaley P
    Int J Pharm Compd; 2013; 17(2):162-4. PubMed ID: 23696177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of ciprofloxacin in an extemporaneous oral liquid dosage form.
    Johnson CE; Wong DV; Hoppe HL; Bhatt-Mehta V
    Int J Pharm Compd; 1998; 2(4):314-7. PubMed ID: 23989641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of flecainide acetate in an extemporaneously compounded oral suspension.
    Wiest DB; Garner SS; Pagacz LR; Zeigler V
    Am J Hosp Pharm; 1992 Jun; 49(6):1467-70. PubMed ID: 1529992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of carbamazepine suspension after repackaging into four types of single-dose containers.
    Lowe DR; Fuller SH; Pesko LJ; Garnett WR; Karnes HT
    Am J Hosp Pharm; 1989 May; 46(5):982-4. PubMed ID: 2729306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of lisinopril in two liquid dosage forms.
    Nahata MC; Morosco RS
    Ann Pharmacother; 2004 Mar; 38(3):396-9. PubMed ID: 14742834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of extemporaneous suspensions of carbamazepine.
    Burckart GJ; Hammond RW; Akers MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1929-31. PubMed ID: 7325176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.